Clik here to view.
What’s Next for Illumina After Roche Deal Falls Through?
Shares of Illumina (NASDAQ:ILMN) were off as much as 10 percent on Monday morning before losses settled to about 6 percent in the early afternoon. Investors are pulling back after Roche Holding...
View ArticleClik here to view.
Flowers In Talks with Hostess, Roche Dumps Illumina: Mergers and Acquisitions...
Flowers Foods (NYSE:FLO): Current price $25.12 Knowledgeable sources say that Flowers Foods and Grupo Bimbo are in talks regarding the purchase of the bread unit of Hostess Brands, as the latter...
View ArticleIllumina Earnings Preview: Can This Streak Continue?
Illumina (NASDAQ:ILMN) will report earnings after markets close on Tuesday, July 23rd. Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic...
View ArticleClik here to view.
4 Mergers and Acquisitions Stock Stories for Midweek Due Diligence
Dell Inc. (NASDAQ:DELL): Current price $12.91 A source told Reuters that the private equity firm Silver Lake, which supports Michael’s Dell’s sweetened $24.6-billion bid for Dell Inc., will not go for...
View ArticleClik here to view.
4 Healthcare Stock Stories for Your Medical Portfolio Wellness
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS): Closing price $36.27 On Thursday, Isis said that follow-up preliminary data from a single dose, open-label Phase 1 study of ISIS-SMN in children suffering from...
View ArticleClik here to view.
Jim Cramer Hungers for Domino’s, Illumina, and Royal Bank of Scotland
Jim Cramer made the following calls on October 15th, 2013. What do you think about his picks? Domino’s Pizza, Inc. (NYSE:DPZ): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a...
View ArticleClik here to view.
4 Healthcare Stock Stories Getting Noticed on Monday
Merck & Co. (NYSE:MRK): Closing price $45.40 A type of HIV medicine that stops the AIDS virus from entering immune system cells might in the future be employed against cancer in new combination...
View ArticleClik here to view.
Vanda’s Sleep Aid for the Blind Nears FDA Approval and 2 Other Hot Stocks to...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA): Current price $12.41 An FDA reviewer said Tuesday that Symantec’s experimental drug – to regulate the circadian rhythms of blind people and help them sleep —...
View ArticleClik here to view.
4 Healthcare Stock Stories Waiting for Your Perusal
Amgen Inc. (NASDAQ:AMGN): Closing price $115.56 On Wednesday, Amgen announced results from the Open Label Study of Long TERm Evaluation Against LDL-C (OSLER) trial, its long-term controlled 52-week...
View ArticleClik here to view.
How Crowdfunding and Open Source Research Will Fight Cancer
Source: Indysci.org What does an open source research approach mean for cancer? How will crowdfunding help develop better drugs faster? How will making a research project’s data accessible to anyone...
View Article